相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy
Yan-Chih Peng et al.
EUROPEAN RADIOLOGY (2021)
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy
Tsuyoshi Takeda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Exercise-induced myokines and their effect on prostate cancer
Jin-Soo Kim et al.
NATURE REVIEWS UROLOGY (2021)
Difference between carbohydrate antigen 19-9 and fluorine-18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual-center study
Hirofumi Akita et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)
Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
Keinosuke Ishido et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)
Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
Takaaki Oba et al.
BMC CANCER (2020)
Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy
Kang Hyun Kim et al.
PANCREATOLOGY (2020)
Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma
Dattatraya Patil et al.
UROLOGY (2020)
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2019)
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
Atsushi Kobayashi et al.
ANNALS OF SURGERY (2019)
L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients
D. Portal et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh M. Griffin et al.
PANCREATOLOGY (2019)
Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy
Naoki Kamitani et al.
SURGERY TODAY (2019)
A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma
Hidetoshi Eguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Patrick Naumann et al.
CANCERS (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review
Frederic Pamoukdjian et al.
CLINICAL NUTRITION (2018)
The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy
Daisaku Yamada et al.
SURGERY TODAY (2018)
Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma: a meta-analysis
Zhongran Man et al.
HPB (2018)
Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer
Moon Hyung Choi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
Louise E. Daly et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer
Marta Sandini et al.
JAMA SURGERY (2018)
Myokines as Possible Therapeutic Targets in Cancer Cachexia
Emilia Manole et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis
Ali A. Mokdad et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study
Go Ninomiya et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
Keiichi Okano et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder
Makito Miyake et al.
BMC CANCER (2017)
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer
Shinya Okumura et al.
SURGERY (2015)
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer
Amanda B. Cooper et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2011)
分享论文
